Physician profile
Thomas Schneider
NPI 1003875360
$15,210.85
in general payments reported to CMS, 2019-2025
54 companies · $2,249 in 2025
The $2,249 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,367 · 2020: $2,042 · 2021: $2,457 · 2022: $2,480 · 2023: $1,826 · 2024: $1,789 · 2025: $2,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,864.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,489.69 | 2019-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,681.60 | 2019-2025 | Nucala, Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,131.34 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $779.46 | 2021-2025 | Dupixent |
| Pfizer INC. | $757.04 | 2019-2025 | |
| Abbvie INC. | $652.59 | 2020-2025 | Ubrelvy, Qulipta, Avycaz |
| Grifols USA, LLC | $584.79 | 2019-2025 | Prolastin-C Liquid |
| Novo Nordisk INC | $572.19 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amarin Pharma, INC. | $528.97 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $441.32 | 2019-2025 | Verquvo, Belsomra, Steglatro |
| Genzyme Corporation | $416.12 | 2019-2025 | |
| Electromed, INC. | $407.30 | 2019-2025 | Smartvest |
| Bayer Healthcare Pharmaceuticals INC. | $382.41 | 2022-2025 | |
| Allergan, INC. | $326.44 | 2019-2020 | |
| Amgen INC. | $295.04 | 2019-2025 | Otezla, Repatha, Evenity |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $278.66 | 2021-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $254.52 | 2019-2023 | Yupelri |
| Abbott Laboratories | $251.65 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Verona Pharma, INC. | $182.40 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $172.44 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $144.07 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $141.69 | 2024-2025 | Gemtesa |
| Philips North America LLC | $121.53 | 2019-2023 | |
| Baxter Healthcare | $115.49 | 2022-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Janssen Pharmaceuticals, INC | $94.13 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.08 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $86.66 | 2020-2024 | Acthar |
| Lilly USA, LLC | $77.21 | 2022-2025 | Zepbound, Mounjaro |
| Insmed, INC. | $71.40 | 2020-2025 | Arikayce |
| Jazz Pharmaceuticals INC. | $58.43 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.34 | 2020-2024 | Glassia, Trintellix |
| E.R. Squibb & Sons, L.L.C. | $52.15 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $50.34 | 2022 | |
| Medtronic, INC. | $47.48 | 2023-2025 | Kyphon Express II Kyphopak Tray, Vanta Adaptivestim |
| Esperion Therapeutics, INC. | $45.96 | 2020-2021 | |
| Pulmonx Corporation | $34.63 | 2022-2023 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Melinta Therapeutics, LLC | $28.94 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $27.15 | 2022 | |
| Inspire Medical Systems, INC. | $26.87 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $24.06 | 2023 | Opsumit |
| Sanofi Pasteur INC. | $23.87 | 2019 | |
| Sanofi-Aventis U.S. LLC | $22.74 | 2021 | |
| Ucb, INC. | $22.15 | 2024 | Cimzia |
| Paratek Pharmaceuticals, INC. | $18.69 | 2023 | Nuzyra |
| Vanda Pharmaceuticals INC. | $16.76 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.80 | 2025 | |
| Hikma Pharmaceuticals USA | $15.50 | 2020 | |
| Circassia INC. | $14.46 | 2019 | |
| Genentech USA, INC. | $14.27 | 2019 | |
| Astellas Pharma US INC | $14.27 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.00 | 2020 | |
| Viatris Specialty LLC | $13.54 | 2025 | Yupelri |
| Daiichi Sankyo INC. | $13.04 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.